Molecular Partners AG is a clinical-stage biopharmaceutical company. The company is headquartered in Schlieren, Switzerland. Show more

WAGISTRASSE 14, SCHLIEREN, SWITZERLAND, 8952, Schlieren, 8952, USA

https://www.molecularpartners.com

BIOTECHNOLOGY

HEALTHCARE

Start AI Chat

Market Cap

154.9M

52 Wk Range

$3.46 - $5.36

Previous Close

$4.05

Open

$4.13

Volume

217

Day Range

$4.13 - $4.13

Enterprise Value

56.75M

Cash

64.25M

Avg Qtr Burn

-14.47M

Insider Ownership

0.00%

Institutional Own.

9.54%

Qtr Updated

03/31/26

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
MP0317 + Durvalumab + SoC Details Advanced cholangiocarcinoma	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
MP0712 (212Pb x DLL3) Details Small cell lung cancer (SCLC)	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
MP0533 (CD33-CD123-CD70) Details High risk myelodysplastic syndromes, Relapsed/refractory acute myeloid leukemia, Acute myeloid leukemia	Phase 1/2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
MP0317 (FAP X CD40) Details Solid tumor/s	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
MP0726 Details Ovarian cancer (mesothelin-overexpressing tumors)	Phase 1 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Ensovibep Details COVID-19	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.